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Neurodegenerative diseases, such as Alzheimer’s or Parkinson’s disease, show characteristic degradation of
structural brain networks. This degradation eventually leads to changes in the network dynamics and degra-
dation of cognitive functions. Here, we model the progression in terms of coupled physical processes: The
accumulation of toxic proteins, given by a nonlinear reaction-diffusion transport process, yields an evolving
brain connectome characterized by weighted edges on which a neuronal-mass model evolves. The progression
of the brain functions can be tested by simulating the resting-state activity on the evolving brain network. We
show that while the evolution of edge weights plays a minor role in the overall progression of the disease,
dynamic biomarkers predict a transition over a period of 10 years associated with strong cognitive decline.
PACS numbers: 87.10.Ed, 87.15.hj, 87.16.Ac, 87.19.L-, 87.19.lp, 87.19.xr
Introduction.—Neurodegenerative diseases are not only ma-
jor health and societal problems [1], they are also formidable
scientific challenges. Their neuropathology, characterized by
diseased brain tissue and cortical atrophy, is linked to the ac-
cumulation of toxic proteins. These structural modifications
change the way neurons interact [2] and lead to cognitive de-
cline and neurobehavioral symptoms [3]. Specifically, axonal
death has a direct effect on the collective brain network dy-
namics, including synchronization [4], dynamics [5, 6] and
connectivity [7]. There are three interconnected physical and
cognitive processes at work: disease progression through the
brain, structural damage created by the disease, and dynamic
changes from damage with the associated functional loss.
Here, we build a model that predict both the spatio-
temporal evolution of the disease but also how it affects ba-
sic cognitive functions. Our approach combines dynamics
on multiple temporal scales (years for the disease and sec-
onds for the resting-state dynamics) with multiphysics at var-
ious levels (transport, aggregation, damage, and oscillations).
Specifically, we look at interacting dynamical processes on an
evolving network structure: Disease progression changes the
structural properties of the brain connectome, which results
in changes to characteristic dynamics of the brain network
dynamics. To probe cognitive functions of a given connec-
tome we simulate whole-brain resting states against functional
magnetic resonance imaging (fMRI) resting-state data [8].
Since Gamma activity emerge in neural populations [9] and
is related to both hippocampal memory formation [10] and
Alzheimer’s disease [11, 12], we use a minimal neural-mass
model with intrinsic frequency in the Gamma range (defined
by Γ = [30, 100] Hz) [13].
Disease progression.—We follow the prion-like
paradigm [14–16], which proposes that degeneration is
caused by the invasion and conformational autocatalytic
conversion of misfolded proteins transported along axonal
pathways. [17]. The prion-like idea has served as an impor-
tant unifying concept through which many features can be
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FIG. 1. The connectome G0 with N = 83 nodes and M = 1654
edges (592 shown).
understood such as staging [18], biomarker evolution [19],
and neural atrophy. Basic models based in this notion recover
most of these observations [20, 21]. The basic features of
these diseases can be obtained by restricting all physical
quantities on the structural connectome, a brain network
representing the connections between different regions of
interest [22–24]. Our model [25, 26], with parameters taken
from [27], combines network diffusion encoded by a graph
Laplacian and a reaction term characterizing the population
amplification due to the conversion of healthy proteins.
We model the connectome as an evolving undirected
weighted graph GT at time T ≥ 0. The initial graph G0
is extracted from from the tractography of diffusion tensor
magnetic resonance images of 418 healthy subjects of the Bu-
dapest Reference Connectome v3.0 [28, 29]. Each node k is
associated with a particular brain region Rs, s = {1, . . . , 7},
corresponding to the frontal, parietal, temporal, occipital
lobes, the limbic area, the basal ganglia, and the brain stem;
cf. Fig. 1. The graph has M edges with weight wkj(T ), be-
tween nodes k and j, defined as the ratio of the number of
fibers between the nodes and the mean fiber length, which
leads to the symmetric matrixW = (wkj), k, j ∈ {1, . . . , N}
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2and the weighted graph Laplacian L = ρ(D −W) where
D = diag(
∑N
j=1wkj) and ρ is an overall velocity constant
defining the time-scale of transport.
Assuming the concentration of healthy proteins remains
mostly unchanged [21], the protein concentration ck(t) at
node k obeys a network discretization of a Fisher–KPP equa-
tion [25] given by
c˙k = −
N∑
j=1
Lkjcj + αck(1− ck), k = 1, . . . , N, (1)
where α characterizes the conversion from healthy to toxic
proteins. Since L depends on the weights W, we require an
equation for the evolution of the weights in time.
Network damage and evolution.—The accumulation of
toxic proteins influences the network properties due to its ef-
fect on synapses, plasticity, and eventual cell death [2, 30, 31].
We quantify the damage at each node by a variable qk ∈ [0, 1]
(0 healthy, 1 maximal damage), for which we assume a first-
order rate model:
q˙k = βck(1− qk), qk(0) = 0, k = 1, . . . , N, (2)
where β characterizes the protein toxicity. Since transport
away from a node depends on the node’s health, the damage at
a node affects the connectivity to other nodes. We assume that
the relative change of an edge weight depend on the damages
at the nodes with a rate γ according to
w˙kj = −γwkj(qk + qj), k, j = 1, . . . , N, (3)
and the systems (1–3) form a closed system of 2N + M or-
dinary differential equations. Initially, the concentration of
toxic proteins vanishes at all nodes except at seeding nodes
that is disease-dependent. For illustrative purpose, we use the
propagation of tau proteins as the main source of toxic protein
and seed the system in the entorhinal region [32] by setting
ck(0) = 0 for all k except for c26(0) = c68(0) = 0.025. Ini-
tially, the connectome is healthy, with qk(0) = 0 for all k, and
the weights wkj(0) are given by G0.
Damage does not slow down disease progression.—Before
considering the resting-state dynamics on an evolving con-
nectome, we study the effect of damage on the propagation
of the disease. To quantify disease progression, we compute
three key structural biomarkers evaluated at a sampled time T :
(a) the average concentration C(T ) = 1N
∑N
j=1 cj(T ), (b) the
average damage Q(T ) = 1N
∑N
j=1 qj(T ), and (c) the scaled
average connection weight W (T ) = ‖W(T )‖/‖W(0)‖,
where ‖W‖ = N−2∑Nk,j=1 wkj . We also compute the av-
erage damage Qs in region s by only summing over indices
inRs and normalizing accordingly.
While one may expect a slowing down of disease progres-
sion as the transport network is affected, the actual overall
effect is negligible as shown in Fig. 2. We first compare C
in the absence of damage (solid curves), with the case of se-
vere damage over a period of 30 years (dotted curve) and see
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FIG. 2. Evolution of averaged toxic concentration and damage. The
black dotted curve (superimposed with the blue solid curve) is the av-
erage concentration in the absence of damage (β = γ = 0) whereas
the solid curve is the case of severe damage (β = (1/4)/year,
γ = (1/8)/year) leading to a reduction of the connection weight
of 50% after 20 years. Even for unrealistic values of the parameters
(β = 4, γ = 2-dashed curve) with a reduction of 99% of all weights
after 15 years, the delay in the evolution of the concentration is only
a year (α = (3/4)/year, ρ = 1/100 mm/year in all simulations).
a negligible difference. Even for unrealistic values (dashed
curves) leading to the destruction of the network within a pe-
riod of 15 years, the delay in invasion is only about a year.
Hence, network damage does not slow down significantly the
invasion of the disease even in extreme cases. Indeed, the re-
duction of diffusion associated with damage mostly affects re-
gions where the concentration is high. In these regions, most
of the tissue is already damaged and only very little transport
is taking place. In terms of front dynamics, the front velocity
in Fisher–KPP depends entirely on the asymptotic zero state.
Once nodes have been seeded, the local increase in concentra-
tion takes place even in the absence of a network. This non-
linear effect due to the conversion of healthy to toxic agents is
fundamentally different than the diffusion process where the
toxic protein must be carried from its source.
Disease staging can be obtained by computing damage in
each region (Fig. 3) [33]. Physical damage first appears in the
limbic region where the disease originates but moves rapidly
to the temporal and parietal lobes. This early invasion can
be understood by looking at the topological properties of the
linearized system [26] (that can be solved explicitly [34] as
shown in the Supplemental Material). Note that increase in
damage in the limbic region is slower than in other regions and
that by year 13 the total damage for example in the temporal
lobe is larger than in the limbic region. Eventually, the disease
invades all cortical areas.
Resting state brain dynamics.—To test the declining cog-
nitive functions of the brain, we focus on resting-state brain
dynamics. The time scales involved in the process are of the
order of months for the disease and of the order of seconds
for the rest-state activity. Therefore, the disease dynamics is
quasi-stationary and at time t = T we consider the connec-
tome GT to be constant when probing resting-state activity.
As a proof of principle, we consider a simple neural-mass
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FIG. 3. Evolution of damage in different brain regions. Physical
damage first manifests itself in the limbic region then moved to the
temporal lobe, the basal ganglia, and the parietal and occipital lobes
before invading all cortical areas.
model on each node representing large interacting excitatory
and inhibitory neural populations to approximate a Wilson–
Cowan type model [13, 35]. In the absence of coupling, the
intrinsic node dynamics are given by a supercritical Hopf bi-
furcation. The state of node k is given by zk ∈ C, and, apart
from an offset, the real part of zk encodes the activity of the
excitatory population and the imaginary part the activity of
the inhibitory population. For a given network GT with asso-
ciated weights W = W(T ) the neural populations are cou-
pled through the amplitude of the excitatory population and
modulated by a sigmoidal function S(x) = 1/(1 + exp(−x))
through the delay differential equation
z˙k = F (zk) + κS
Re
 N∑
j=1
wkjzj(t− τkj)
 , (4)
where F (zk) = z
(
λ + iωk −
∣∣z2k∣∣ ) with decay λ = −0.01,
intrinsic frequencies ωk = ω + δk = 40Hz + δk whose devi-
ations δk are sampled from a normal distribution (mean zero,
variance 0.1Hz), coupling gain κ = 10, and delays τkj pro-
portional to the distance between node k and j from the con-
nectome data with transmission speed of 1.5m/s (discretized
to have a maximum of 40 distinct delays); these model pa-
rameters were chosen to approximate the neural-mass model
in [13] validated against resting-state fMRI. For the initial
graph G0, we observe collective oscillations. In the absence of
coupling, all amplitudes decay exponentially with a frequency
of around 40Hz.
Global cognitive decline after physical damage—As in-
dicators of cognitive processes, we consider three dynamic
biomarkers obtained from tsim = 10s of resting-state dynam-
ics (4): (d) the overall power in the Gamma-range P (T ) =∫
Γ
PSD(〈z〉)(Ω) dΩ, where PSD is the power spectral den-
sity of the signal 〈z〉 = 1N
∑N
j=1 Re(zj), (e) the average os-
cillatory activity A(T ) = N−1
∑N
j=1 t
−1
sim
∫ tsim
0
|zj(t)| dt, and
(f) the metastability index B(T ) = N−1
∑N
j=1 σ
2
t (|zj(t)|),
where σ2t is the variance of the signal over the time interval
FIG. 4. Dynamic biomarkers are stable up to year 10 followed by a
rapid decline from year 16 onward. (a) power in the Γ band; (b) oscil-
lation mean amplitude; there are no oscillations in the absence of net-
work coupling. (c) mean variability which indicates non-stationary
(and potentially metastable) brain dynamics. Mean and standard de-
viation for 12 realizations with different intrinsic frequencies and ini-
tial conditions (solid gray line is C(T ) for comparison).
[0, tsim]. We define the corresponding measures Ps, As, Bs
forRs by summing over the corresponding nodes and normal-
izing accordingly. These dynamic biomarkers have been as-
sociated with cognitive processes and neurodegenerative dis-
eases [4]. The average amplitude is a measure of the general
activity and the metastability index is associated with infor-
mation processing [36–39].
To evaluate how the disease affects the dynamics, we
solved (4) on the evolving brain connectome for different
times T ; see Supplemental Material for details. Fig. 4 shows
the mean and standard deviations of the dynamical biomark-
ers scaled with respect to the healthy response at T = 0. We
see that all dynamical indicators remain fairly unchanged up
to year 20 as the disease progresses. At that time, the brain has
already suffered significant physical damage even if this dam-
age cannot be easily assessed from the dynamics (see Fig. 2).
It suggests that the brain state is structurally stable against
damages for an extended time. However, after 20 years, the
dynamics undergoes a clear transition when nodes are unable
to sustain oscillatory activities.
The local dynamical biomarkers show a more differentiated
picture of how the spreading disease changes the dynamics.
The transition of the global dynamics is preceded by a de-
cay of oscillatory activity in the temporal lobe. In terms of
the oscillatory activity, the markers for all other regions are
close to the global mean (Fig. 4b). Given that damage first
4FIG. 5. Oscillation amplitude changes with the homeostasis pa-
rameter. Increasing homeostasis does not lead to a shift in the onset
of decline but only changes the shape of the decline. The global
mean oscillation amplitude (gray lines) shows how the slope varies
for different homeostasis parameters; in the extreme case ξ = 1, the
oscillation amplitude remains constant. By contrast, the mean am-
plitude in the temporal lobe (blue lines) decreases in any case. For
comparison, C(T ) is given by the solid gray line.
accumulates in the limbic system (Fig. 3), this observation
may be counterintuitive. However, it indicates that both speed
of damage accumulation and network structure determine the
critical threshold for the decay of oscillatory dynamics: The
region where one first sees significant structural damage can
be distinct from the region that first undergoes a dynamical
transition. This is consistent with experimental findings that
indicate that temporal lobe activity is a precursor for the dis-
ease onset [40].
Adaptation slows cognitive decline.—Connections between
neurons are typically not static but adjust in response to the
dynamics [41, 42]. Thus, in addition to damage-induced
changes to the network, the neural dynamics itself affects the
network to maintain homeostasis [43]. To capture this effect,
we implement a minimal model of homeostatic adaptation that
aims to keep the mean connectome coupling constant over
time. For an adaptation parameter ξ ∈ [0, 1], we define the
scaled matrix withW(0) = W(0) and
W(T ) =
(
(1− ξ) + ξ
(‖W(T − 1)‖
‖W(T )‖
))
W(T ) (5)
for T = 1, 2, . . . . This homeostatic adaptation creates a new
weighted connectome for the resting-state dynamics (4) for
every year T of disease progression. Through (5), home-
ostasis acts by globally rescaling the coupling weights. For
ξ = 0, there is no homeostatic adaptation and the network
structure changes solely through the disease progression. For
ξ = 1, there is complete homeostatic adaptation in the sense
that we have a constant mean coupling weight ‖W(T )‖ = 1
for all T . This does not imply W(T ) = W(0). Rather, due
to the global nature of the homeostatic adaptation, disease-
induced changes in coupling strength in one brain region will
yield hyper-excitability in another brain region to balance the
overall decay in coupling strength.
Homeostatic adaptation modulates the disease progression.
We simulated the resting-state dynamics (4) subject to the
homeostatic adaptation (5). Fig. 5 shows the average ampli-
tude A(T ) as disease progresses for different values of the
adaptation parameter ξ. An increase in homeostasis does not
change the actual onset of loss of oscillatory activity (around
year 13) but yields a slow-down of the degeneration. How-
ever, assuming that cognitive decline sets in once a certain
threshold is reached, the slow-down of disease progression
will alter the onset of the overall transition. Fig. 5 also shows
mean oscillation amplitude for the temporal lobe. The tem-
poral lobe shows a decay in oscillatory activity for all val-
ues of the adaptation parameters preceding the overall decay
of oscillatory activity. This happens even for full adaptation,
ξ = 1, where the overall oscillatory activity stays constant in
the time-window considered here. This decline implies that
other brain areas have to be upregulated in order to keep the
overall activity almost constant. However, it also means that
for our simple model of adaptation, the variation of oscilla-
tion amplitude is a precursor for the overall transition of the
dynamics independently of the adaptation parameter.
Discussion.—Compared to previous studies that focused on
either static properties of the declining network [44], synchro-
nization [4] or activity-based decline [45], we focused on the
importance of the underlying interacting physical processes.
The physical damage of the brain and neural dynamics—two
independent yet coupled processes—interact on the same con-
nectome. Neurodegeneration, modeled as an invasion process
due to the accumulation of toxic proteins, provides a natu-
ral evolution of the connectome on long time scales that can
be probed dynamically on short time scales. Our observa-
tions are compatible with the activity-dependent spreading hy-
pothesis [45]: toxic proteins will spread predominantly along
highly connected nodes which also show high activity due to
the amount of input they receive.
While the actual brain connectome is not an undirected
graph, there is very little information on directionality for
the human brain. However, an analysis of a mesocale mouse
connectome [46] that has been used for toxic protein diffu-
sion [24, 47] reveals that asymmetry delays significantly the
onset of the disease but preserves its main characteristics (see
Supplemental Material).
Our setup provides a unified framework that combines the
biophysics of disease spreading with whole-brain dynamics to
give mechanistic insights into the dynamics of neurodegener-
ative diseases and its associated cognitive decline. First, we
showed that damage does not slow the disease propagation as
damage is delayed with respect to seeding. Very low level
of toxic proteins diffuse and seed new regions. Then, even
in the absence of transport, there is a local autocatalytic in-
crease of toxic protein. Second, we gained insight into the dy-
namical transitions appearing in some brain regions and con-
firms the prediction [40] that the temporal lobe is one of the
first to see alteration in brain dynamics, hence showing cog-
nitive deficiencies related to that region for Alzheimer’s dis-
ease as shown in Fig. 4. Third, our results elucidate the in-
terplay between network adaptation and spreading. We found
that incorporating a simple model of global homeostasis does
not change the onset of dynamical changes, but how fast they
evolve as the disease progresses. Interestingly, we saw that, in
the particular case of Alzheimer disease, a decline of oscilla-
5tions in the temporal lobe is a universal indicator independent
of the adaptation parameter.
Further insights are needed on how the multiphysics of
disease propagation interact with brain network dynamics to
identify reliable noninvasive biomarkers to assess disease pro-
gression as early as possible and develop an integrated ap-
proach for treatment. Other models for whole-brain dynam-
ics are available that focus on different features of brain dy-
namics [8] and relate to microscopic neural properties [48].
When combined with data from a comprehensive longitudi-
nal study and suitable dynamical models, our approach will
be able to explore new treatment approaches and intervention
scenarios on the combined level of network structure and dy-
namics [2, 49, 50].
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